Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Craig Leonardi"'
Autor:
Lluís Puig, Hideki Fujita, Diamant Thaçi, Min Zheng, Ana Cristina Hernandez Daly, Craig Leonardi, Mark G. Lebwohl, Jonathan Barker
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2331-2378 (2024)
Abstract Generalized pustular psoriasis (GPP) is a rare, chronic and potentially life-threatening autoinflammatory skin disease characterized by widespread eruption of sterile pustules, with or without systemic inflammation. GPP can significantly red
Externí odkaz:
https://doaj.org/article/6a3c54cabc414da3a8ccb8b021e75083
Autor:
Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn Guenther, Melinda Gooderham, Laura K. Ferris, Christopher E. M. Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim Papp
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 3, Pp 431-447 (2020)
Abstract Introduction Ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17A, is approved for treatment of moderate-to-severe plaque psoriasis. Our objective was to evaluate the long-term efficacy and safety of ixeki
Externí odkaz:
https://doaj.org/article/9fcdd75b0c314187bca955c0a6fd2339
Autor:
Elsie Grace, Orin Goldblum, Lisa Renda, Noah Agada, Kyoungah See, Craig Leonardi, Alan Menter
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 1, Pp 99-106 (2019)
Abstract Introduction Biologics used to treat moderate-to-severe plaque psoriasis may cause injection site reactions (ISRs) characterized by erythema, edema, itch, and sometimes pain. The Federal Adverse Event Reporting System (FAERS) is a repository
Externí odkaz:
https://doaj.org/article/0cc261313ed54acebcb23ebff0d1c0df
Autor:
James G Krueger, Mayte Suárez-Fariñas, Inna Cueto, Artemis Khacherian, Robert Matheson, Lawrence C Parish, Craig Leonardi, Denise Shortino, Akanksha Gupta, Jonathan Haddad, George P Vlasuk, Eric W Jacobson
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142081 (2015)
Activation of Sirtuin (silent mating type information regulation 2 homolog) 1, or SIRT1, is an unexplored therapeutic approach for treatment of inflammatory diseases. We randomized 40 patients with moderate-to-severe psoriasis (4:1) to three escalati
Externí odkaz:
https://doaj.org/article/9e19d739bed14e038b7414b6243efab0
Autor:
Knut M Wittkowski, Craig Leonardi, Alice Gottlieb, Alan Menter, Gerald G Krueger, Paul W Tebbey, Jennifer Belasco, Razieh Soltani-Arabshahi, John Gray, Liz Horn, James G Krueger, International Psoriasis Council
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20279 (2011)
This study correlated assessment tools for evaluating the severity of skin, nail, and joint symptoms in patients with psoriasis (Pso) and psoriatic arthritis (PsA). Adults with plaque Pso (with or without PsA) were enrolled from four U.S. institution
Externí odkaz:
https://doaj.org/article/ac45086cb532479b918d24f2adb3321d
Autor:
Mark Lebwohl, John Koo, Craig Leonardi, April Armstrong, Nicole Rawnsley, Earl Goehring, Abby Jacobson
Publikováno v:
Journal of Drugs in Dermatology. 22:419-422
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5861b599bb87a74b3ddf9574046c0e6b
https://doi.org/10.36849/jdd.7344
https://doi.org/10.36849/jdd.7344
Autor:
Craig, Leonardi, Baojin, Zhu, William N, Malatestinic, William J, Eastman, Jiaying, Guo, Mwangi J, Murage, Casey Kar-Chan, Choong, Russel, Burge, Andrew, Blauvelt
Publikováno v:
Advances in Therapy. 39:3214-3224
Limited real-world data are available comparing multiple biologics on their adherence, persistence, and the use of concomitant biologics in the treatment of moderate-to-severe psoriasis in clinical practice. The objective was to compare persistence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c453a7c39f55e66d77c7f49e4dc9477
https://doi.org/10.1007/s12325-022-02155-9
https://doi.org/10.1007/s12325-022-02155-9
Autor:
April Armstrong, Kyle Fahrbach, Craig Leonardi, Matthias Augustin, Binod Neupane, Paulina Kazmierska, Marissa Betts, Andreas Freitag, Sandeep Kiri, Vanessa Taieb, Mahmoud Slim, Natalie Nunez Gomez, Richard B. Warren
Publikováno v:
Dermatology and therapy. 12(8)
Biologic treatments are increasingly being used in the management of moderate to severe plaque psoriasis (PSO). Bimekizumab is a selective inhibitor of both interleukin (IL)-17A and IL-17F approved for the treatment of moderate to severe PSO. Althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03a9afe6e534ae4fc368d2f17e6eae3e
https://pubmed.ncbi.nlm.nih.gov/35798920
https://pubmed.ncbi.nlm.nih.gov/35798920
Autor:
Hendrik Schulze-Koops, Atul Deodhar, Reinhard E. Voll, Jan Leipe, Andrew Blauvelt, Craig Leonardi, Effie Pournara, Ivette Alarcon, Weibin Bao, Vivek Trivedi, Philip J. Mease
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bb7b4147f92e5f7ed0a1e861db7290
https://doi.org/10.1016/j.jaad.2022.06.800
https://doi.org/10.1016/j.jaad.2022.06.800
Autor:
April W. Armstrong, Richard B. Warren, Howard Sofen, Lynda Spelman, Craig Leonardi, Subhashis Banerjee, Tao Wang, John Throup, Elizabeth Colston, Andrew Napoli, Alexa B. Kimball
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31f0c246e5a14c59986cc89e1c7ed484
https://doi.org/10.1016/j.jaad.2022.06.657
https://doi.org/10.1016/j.jaad.2022.06.657